 |
|
Eye-Preserving Therapy in Retinoblastoma: Prolonged Primary Chemotherapy Alone or Combined with Local Therapy
Joo Young Shin, Jeong Hun Kim, Young Suk Yu, Sang In Khwarg, Ho Kyung Choung, Hee Young Shin, Hyo Seop Ahn
Korean J Ophthalmol. 2010;24(4):219-224. Published online 2010 Aug 3 DOI: https://doi.org/10.3341/kjo.2010.24.4.219
|
|
Citations to this article as recorded by
 Update on chemotherapy modalities for retinoblastoma: Progress and challenges
Thanaporn Kritfuangfoo, Duangnate Rojanaporn
Asia-Pacific Journal of Ophthalmology.2024; 13(2): 100061. CrossRef Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma
Debora H. Lee, Richard Donkor, Matthew N. Parvus, Mark J. Dannenbaum, Amy C. Schefler
JAMA Ophthalmology.2023; 141(12): 1133. CrossRef Ocular surface complications of local anticancer drugs for treatment of ocular tumors
Jayoon Moon, Se Hyun Choi, Min Joung Lee, Dong Hyun Jo, Un Chul Park, Sun-Ok Yoon, Se Joon Woo, Joo Youn Oh
The Ocular Surface.2021; 19: 16. CrossRef Development of New Solitary Retinoblastoma Tumors during and after Chemotherapy
Won Jong Choi, Dong Hyun Jo, Hyoung Jin Kang, Hee Young Shin, Young Suk Yu, Jeong Hun Kim
Korean Journal of Ophthalmology.2021; 35(1): 73. CrossRef Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class—A Meta-Analysis
Anthony B. Daniels, Shriji N. Patel, Ronald W. Milam, Sahar Kohanim, Debra L. Friedman, Tatsuki Koyama
Cancers.2021; 13(9): 2216. CrossRef Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)
Christina Stathopoulos, Livia Lumbroso-Le Rouic, Annette C. Moll, Manoj Parulekar, Philippe Maeder, François Doz, Helen Jenkinson, Maja Beck Popovic, Guillermo Chantada, Francis L. Munier
Cancers.2021; 13(14): 3392. CrossRef Intravenous Chemotherapy for Retinoblastoma in the Era of Intravitreal Chemotherapy: A Systematic Review
Vishal Raval, Randy Christopher Bowen, Hansell Soto, Arun Singh
Ocular Oncology and Pathology.2021; 7(2): 142. CrossRef Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma
Qiuying Chen, Bin Zhang, Yuhao Dong, Xiaokai Mo, Lu Zhang, Jiejun Xia, Jing Zhang, Shuixing Zhang
Cancer Chemotherapy and Pharmacology.2020; 85(4): 723. CrossRef Targeting tyrosine kinases for treatment of ocular tumors
Dong Hyun Jo, Jin Hyoung Kim, Jeong Hun Kim
Archives of Pharmacal Research.2019; 42(4): 305. CrossRef Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”
Francis L. Munier, Maja Beck-Popovic, Guillermo L. Chantada, David Cobrinik, Tero T. Kivelä, Dietmar Lohmann, Philippe Maeder, Annette C. Moll, Angel Montero Carcaboso, Alexandre Moulin, Paula Schaiquevich, Ciara Bergin, Paul J. Dyson, Susan Houghton, Fra
Progress in Retinal and Eye Research.2019; 73: 100764. CrossRef Retinoblastoma: The importance of early diagnosis
M. Parrilla-Vallejo, R. Perea-Pérez, I. Relimpio-López, I. Montero-de-Espinosa, E. Rodríguez-de-la-Rúa, J.A. Terrón-León, M.J. Díaz-Granda, L. Coca-Gutiérrez, B. Ponte-Zuñiga, F. Espejo-Arjona
Archivos de la Sociedad Española de Oftalmología (English Edition).2018; 93(9): 423. CrossRef Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis
Qiuying Chen, Bin Zhang, Yuhao Dong, Xiaokai Mo, Lu Zhang, Wenhui Huang, Hua Jiang, Jiejun Xia, Shuixing Zhang
BMC Cancer.2018;[Epub] CrossRef Retinoblastoma: la importancia de su diagnóstico precoz
M. Parrilla-Vallejo, R. Perea-Pérez, I. Relimpio-López, I. Montero-de-Espinosa, E. Rodríguez-de-la-Rúa, J.A. Terrón-León, M.J. Díaz-Granda, L. Coca-Gutiérrez, B. Ponte-Zuñiga, F. Espejo-Arjona
Archivos de la Sociedad Española de Oftalmología.2018; 93(9): 423. CrossRef Unusually very late-onset new growth of intraocular retinoblastoma: A case report and review of literature
Yeshigeta Gelaw, Shoeib Mohamed Shoukry, Ihab Saad Othman
American Journal of Ophthalmology Case Reports.2017; 5: 130. CrossRef Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis
Ido D Fabian, Andrew W Stacey, Kenneth P Johnson, Zerrin Onadim, Tanzina Chowdhury, Catriona Duncan, M Ashwin Reddy, Mandeep S Sagoo
British Journal of Ophthalmology.2017; 101(1): 82. CrossRef Outcomes of Cataract Surgery Following Treatment for Retinoblastoma
Hyeong Min Kim, Byung Joo Lee, Jeong Hun Kim, Young Suk Yu
Korean Journal of Ophthalmology.2017; 31(1): 52. CrossRef Retinoblastoma
Charlotte Y. Chung, Carlos A. Medina, Hassan A. Aziz, Arun D. Singh
International Ophthalmology Clinics.2015; 55(1): 63. CrossRef Clinical Efficacy and Prognostic Factors of Chemoreduction Combined with Topical Treatment for Advanced Intraocular Retinoblastoma
Yan Liu, Xi Zhang, Fang Liu, Ke-Lei Wang
Asian Pacific Journal of Cancer Prevention.2014; 15(18): 7805. CrossRef Long‐term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low‐dose IMRT salvage
Jesse L. Berry, Rima Jubran, Jonathan W. Kim, Kenneth Wong, Simon R. Bababeygy, Hashem Almarzouki, Thomas C. Lee, A. Linn Murphree
Pediatric Blood & Cancer.2013; 60(4): 688. CrossRef Consideraciones clínicas, diagnósticas y de tratamiento en retinoblastoma
John Fredy Villamil Duarte, Lina María Quintero Pérez, Ronald Andrés Serrano Uribe, Ivonne Andrea Moreno Martínez
MedUNAB.2011; 14(3): 180. CrossRef
|